Gain Therapeutics GANX Income Statement (2020-2026)

NASDAQ GANX
$1.98 -0.09 (-4.35%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue (Quarter)
0.03M0.01M0.05M0.10M-0.01M0.06M
Operating items
Research & Development (Quarter)
2.48M1.47M1.56M2.58M1.96M2.27M2.79M3.99M2.37M2.37M2.51M4.44M2.62M1.22M2.26M2.76M2.85M2.35M2.76M2.14M
Selling, General & Administrative (Quarter)
2.19M1.78M1.78M2.69M2.79M2.29M2.49M3.74M2.52M2.03M1.87M3.75M1.84M2.11M2.11M2.33M1.94M2.12M2.59M2.54M
Operating Expenses (Quarter)
4.66M3.25M3.33M5.27M4.75M4.56M5.28M7.73M4.89M4.41M4.38M8.18M4.46M3.33M4.37M5.09M4.79M4.47M5.35M4.68M
Operating Income (Quarter)
-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M-4.47M-5.35M-4.68M
EBIT (Quarter)
-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M-4.47M-5.35M-4.68M
Non-operating items
Other Non Operating Income (Quarter)
-0.03M-0.02M0.02M0.04M0.04M-0.20M-0.04M-0.06M0.08M-0.41M0.27M-0.04M-0.12M0.02M-0.10M-0.62M-0.03M1.60M-0.17M0.05M
Non Operating Income (Quarter)
0.12M0.08M0.11M0.05M0.04M0.04M0.08M0.08M0.09M0.06M
Net income details
EBT (Quarter)
-4.66M-3.23M-3.27M-5.08M-4.55M12.75M-5.12M-7.66M-4.70M-5.00M-3.99M-8.14M-4.47M-3.26M-4.43M-5.67M-4.74M-4.47M-5.43M-4.57M
Tax Provisions (Quarter)
0.01M-0.01M0.00M0.01M0.00M0.08M0.02M0.03M0.02M0.01M0.02M0.00M0.01M0.50M0.10M0.14M0.55M-4.84M0.18M0.10M
Profit After Tax (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M-4.67M-5.14M-7.69M-4.72M-4.72M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M16.47M-5.61M-4.68M
Income from Non-Controlling Interests (Quarter)
0.01M0.01M0.01M
Income from Continuing Operations (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M0.38M-5.61M-4.68M
Consolidated Net Income (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M0.38M-5.61M-4.68M
Income towards Parent Company (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M0.38M-5.61M-4.68M
Net Income towards Common Stockholders (Quarter)
-4.66M-3.22M-3.27M-5.09M-4.56M12.67M-5.14M-7.69M-4.72M-5.01M-4.01M-8.14M-4.49M-3.77M-4.53M-5.81M-5.28M0.38M-5.61M-4.68M
Additional items
EPS (Basic) (Quarter)
-0.39-0.32-0.28-0.43-0.381.07-0.43-0.62-0.37-0.39-0.22-0.42-0.17-0.16-0.16-0.19-0.150.01-0.13-0.11
EPS (Diluted) (Quarter)
-0.39-0.32-0.28-0.43-0.381.07-0.43-0.62-0.37-0.39-0.22-0.42-0.17-0.16-0.16-0.19-0.150.01-0.13-0.11
Shares Outstanding (Quarter)
11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.39M12.70M13.01M17.98M19.22M26.53M22.88M28.69M30.34M35.00M32.97M42.23M42.88M
Shares Outstanding (Diluted) (Quarter)
11.88M10.17M11.88M11.88M11.88M11.88M11.94M12.39M12.70M13.01M17.98M19.22M26.53M22.88M28.69M30.34M35.00M32.97M42.23M42.88M
Shares Outstanding (Entity) (Quarter)
11.88M11.88M11.88M11.88M11.88M11.88M12.09M12.63M12.78M13.01M18.04M19.22M25.96M27.13M28.75M30.77M35.98M32.97M42.49M43.34M
EBITDA (Quarter)
-4.64M-3.21M-3.29M-5.18M-4.75M-4.56M-5.23M-7.73M-4.89M-4.41M-4.38M-8.18M-4.46M-3.33M-4.37M-5.09M-4.79M-4.47M-5.35M-4.68M
Interest Expenses (Quarter)
2.600.15M9.44M0.05M0.05M0.02M0.15M0.39M0.33M0.28M0.17M0.18M0.00M0.18M0.36M0.03M0.29M
Tax Rate (Quarter)
-0.11%0.26%-0.05%-0.18%-0.09%0.61%-0.33%-0.35%-0.46%-0.29%-0.50%-0.01%-0.25%-15.47%-2.27%-2.49%-11.59%108.43%-3.37%-2.28%